NOMOS Corporation is a leading supplier of planning and delivery technology for Intensity Modulated Radiation Therapy (IMRT). NOMOS Non-Invasive Scalpel IMRT allows an escalated radiation dose to be delivered to a tumor while limiting exposure and damage to nearby healthy tissue. More than 25,000 patients worldwide have safely received IMRT treatments at hospitals equipped with NOMOS' PEACOCK, CORVUS and MIMiC systems. In addition, NOMOS offers both BAT, a unique ultrasound-based organ locator used primarily in prostate cancer treatments, and PEREGRINE, the first and only commercially available photon-based dose calculation system to incorporate state-of-the-art Monte Carlo radiation transport techniques to more accurately predict the radiation dose delivered to tumors and other structures within a patient's body "before" radiation treatment is delivered.